The Drug-Induced Respiratory Disease Website

II - Myocardial dysfunction - Heart failure

II.d

Cardiovascular collapse - Cardiogenic shock - Hypotension

1

Evidence level

low

III - Myocardial ischemia - Coronary artery disease

III.a

Coronary artery disease (acute) - Myocardial ischemia/infarction

1

Evidence level

low

III.c

Coronary vasospasm - Vasospastic angina

1

Evidence level

low

XV - Chest pain

XV.a

Chest pain (acute or subacute), lone or prominent

1

Evidence level

low

XVI - Hemorrhage - Bleeding - Hematoma(s)

XVI.e

Alveolar hemorrhage (AH), diffuse AH (DAH)

1

Evidence level

low

XXII - Acute respiratory/cardiorespiratory failure

XXII.b

Acute lung injury - ARDS

1

Evidence level

low

XXIV - Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis

XXIV.a

Pneumonitis (ILD)

1

Evidence level

low

XXIV.f

Diffuse alveolar damage (DAD) imaging pattern

1

Evidence level

low

XXVIII - Large airway involvement

XXVIII.a

Angioedema (may cause UAO, asphyxia and death)

1

Evidence level

low

XXIX - Small airway involvement

XXIX.a

Bronchospasm - Wheezing - Asthma

1

Evidence level

low

XXX - Imaging features

XXX.l

Imaging: Ground-glass opacities / GGO shadowing

1

Evidence level

low

XXXVI - Autoimmune syndromes - Systemic reactions or conditions

XXXVI.f

Anaphylaxis - Anaphylactoid reaction (either of these can be fatal)

1

Evidence level

low

XXXVIII - Miscellaneous - Varia

XXXVIII.k

Hypersensitivity reaction (may manifest with fever and/or skin, throat or airway involvement)

2

Evidence level

possible